Literature DB >> 23397264

Expression pattern of id proteins in medulloblastoma.

Andrew D Snyder1, Ashley N Dulin-Smith, Ronald H Houston, Ashley N Durban, Bethany J Brisbin, Tyler D Oostra, Jordan T Marshall, Basil M Kahwash, Christopher R Pierson.   

Abstract

Inhibitor of DNA binding or inhibitor of differentiation (Id) proteins are up regulated in a variety of neoplasms, particularly in association with high-grade, poorly differentiated tumors, while differentiated tissues show little or no Id expression. The four Id genes are members of the helix-loop-helix (HLH) family of transcription factors and act as negative regulators of transcription by binding to and sequestering HLH complexes. We tested the hypothesis that Id proteins are overexpressed in medulloblastoma by performing immunohistochemistry using a medulloblastoma tissue microarray with 45 unique medulloblastoma and 11 normal control cerebella, and antibodies specific for Id1, Id2, Id3, and Id4. A semi-quantitative staining score that took staining intensity and the proportion of immunoreactive cells into account was used. Id1 was not detected in normal cerebella or in medulloblastoma cells, but 78 % of tumors showed strong Id1 expression in endothelial nuclei of tumor vessels. Id2 expression was scant in normal cerebella and increased in medulloblastoma (median staining score: 4). Id3 expression was noted in some neurons of the developing cerebellar cortex, but it was markedly up regulated in medulloblastoma (median staining score: 12) and in tumor endothelial cells. Id4 was not expressed in normal cerebella or in tumor cells. Id2 or Id3 overexpression drove proliferation in medulloblastoma cell lines by altering the expression of critical cell cycle regulatory proteins in favor of cell proliferation. This study shows that Id1 expression in endothelial cells may contribute to angiogenic processes and that increased expression of Id2 and Id3 in medulloblastoma is potentially involved in tumor cell proliferation and survival.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23397264      PMCID: PMC3826575          DOI: 10.1007/s12253-012-9599-4

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  30 in total

1.  Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence.

Authors:  N Ohtani; Z Zebedee; T J Huot; J A Stinson; M Sugimoto; Y Ohashi; A D Sharrocks; G Peters; E Hara
Journal:  Nature       Date:  2001-02-22       Impact factor: 49.962

Review 2.  Role of Id family proteins in growth control.

Authors:  Yoshifumi Yokota; Seiichi Mori
Journal:  J Cell Physiol       Date:  2002-01       Impact factor: 6.384

Review 3.  Id proteins in cell cycle control and cellular senescence.

Authors:  Z Zebedee; E Hara
Journal:  Oncogene       Date:  2001-12-20       Impact factor: 9.867

Review 4.  Inhibitors of DNA binding in neural cell proliferation and differentiation.

Authors:  Shun-Fen Tzeng
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

5.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.

Authors:  D Lyden; A Z Young; D Zagzag; W Yan; W Gerald; R O'Reilly; B L Bader; R O Hynes; Y Zhuang; K Manova; R Benezra
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

6.  Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors.

Authors:  Dmitri A A Vandeputte; Dirk Troost; Sieger Leenstra; Helen Ijlst-Keizers; Marja Ramkema; D Andries Bosch; Frank Baas; Nab K Das; Eleonora Aronica
Journal:  Glia       Date:  2002-06       Impact factor: 7.452

7.  Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.

Authors:  M D Ris; R Packer; J Goldwein; D Jones-Wallace; J M Boyett
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

8.  Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade.

Authors:  G Bain; C B Cravatt; C Loomans; J Alberola-Ila; S M Hedrick; C Murre
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

9.  Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins.

Authors:  A Lasorella; M Noseda; M Beyna; Y Yokota; A Iavarone
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

10.  Molecular subgroups of medulloblastoma: the current consensus.

Authors:  Michael D Taylor; Paul A Northcott; Andrey Korshunov; Marc Remke; Yoon-Jae Cho; Steven C Clifford; Charles G Eberhart; D Williams Parsons; Stefan Rutkowski; Amar Gajjar; David W Ellison; Peter Lichter; Richard J Gilbertson; Scott L Pomeroy; Marcel Kool; Stefan M Pfister
Journal:  Acta Neuropathol       Date:  2011-12-02       Impact factor: 17.088

View more
  2 in total

Review 1.  The Id-protein family in developmental and cancer-associated pathways.

Authors:  Cornelia Roschger; Chiara Cabrele
Journal:  Cell Commun Signal       Date:  2017-01-25       Impact factor: 5.712

2.  Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.

Authors:  David Bakhshinyan; Ashley A Adile; Jeff Liu; William D Gwynne; Yujin Suk; Stefan Custers; Ian Burns; Mohini Singh; Nicole McFarlane; Minomi K Subapanditha; Maleeha A Qazi; Parvez Vora; Michelle M Kameda-Smith; Neil Savage; Kim L Desmond; Nazanin Tatari; Damian Tran; Mathieu Seyfrid; Kristin Hope; Nicholas A Bock; Chitra Venugopal; Gary D Bader; Sheila K Singh
Journal:  Sci Adv       Date:  2021-12-08       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.